HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
A webcast of the fireside chat will be available on the investor page of Harmony's website at .PLYMOUTH MEETING, Pa., Nov. 21, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in the following upcoming investor conferences:
2024年11月21日，宾夕法尼亚州普利茅斯会议，和睦生物科技控股公司（纳斯达克股票代码：HRMY）今天宣布和睦的管理团队将参加以下即将举行的投资者会议：
Citi's 2024 Global Healthcare Conference
花旗银行2024年全球医疗保健会议
- Location: Miami
- Tuesday, December 3, 2024
- 地点：迈阿密
- 2024年12月3日星期二
Piper Sandler 36th Annual Healthcare Conference
派杰投资第36届医疗保健年会
- Location: New York City
- Fireside Chat: Wednesday, December 4, 2024, at 8:30 a.m., ET
- 地点：纽约市
- 炉边访谈：2024年12月4日，东部时间上午8:30
A webcast of the fireside chat will be available on the investor page of Harmony's website at .
炉边访谈的网络直播将在和睦网站的投资者页面上提供。 .
About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, we believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we foster. For more information, please visit .
Harmony生物科学
Harmony Biosciences是一家致力于为患有罕见神经系统疾病且医疗需求未被满足的患者开发和推广创新疗法的药品公司。在新颖的科学、有远见的思维和对感到被忽视的人的承诺的驱动下，Harmony Biosciences正在孕育一个充满治疗可能性的未来，这可能使患有罕见神经系统疾病的患者真正茁壮成长。由Paragon Biosciences, LLC于2017年成立，总部位于宾夕法尼亚州普利茅斯会议，我们相信当同理心和创新相遇时，更美好的未来可以开始；这一愿景体现在我们推进的治疗创新、我们培育的文化和我们促进的社区项目中。欲了解更多信息，请访问 .
Harmony Biosciences Investor Contact:
Brennan Doyle
484-539-9700
[email protected]
Harmony生物科学投资人联系方式：
Brennan Doyle
484-539-9700
[email protected]
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
[email protected]
Harmony生物科学媒体联系方式：
凯特·麦坎莱斯（Cate McCanless）
202-641-6086
[email protected]
SOURCE Harmony Biosciences
消息来源：Harmony生物科学
